Owens & Minor

Owens & Minor, Inc. engages in the provision of healthcare solutions. It operates through the Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Owens & Minor achieves record revenue, focuses on cost-saving initiatives

Owens & Minor's Q4 2022 performance reflects record revenue, strong segment growth, and strategic initiatives to drive profitability and operational efficiency.
While facing challenges in certain divisions, the company's focus on cost-saving programs and market competitiveness positions it well for future growth and success.
With a positive outlook for 2023, Owens & Minor aims to capitalize on opportunities for growth, cash flow improvement, and market expansion to drive shareholder value.

Owens & Minor reports solid Q1 results, raises 2023 outlook

Owens & Minor's Q1 performance reflects a mix of successes and challenges, with a strong focus on realignment and debt reduction. The company is optimistic about future growth prospects, particularly in the patient direct segment, and remains committed to enhancing operational efficiency and capital deployment.

Owens & Minor reports strong Q2 performance amidst PPE challenges

Owens & Minor's Q2 performance reflects positive momentum with growth in key segments and a focus on financial health through debt reduction.
Challenges in the PPE market and uncertainties in demand highlight the need for strategic planning and risk management strategies.
The company's strengths in revenue growth drivers and new business contracts position it well for future growth opportunities and financial success.

Owens & Minor (OMI) posts strong Q3 results, eyes growth opportunities

Owens & Minor (OMI) reported a solid Q3 performance with revenue growth, debt reduction, and operational efficiency driving financial resilience.
While facing challenges in market visibility and regulatory changes, the company remains well-positioned to capitalize on growth opportunities and enhance shareholder value.
Strategic focus on key segments and profitability improvement initiatives set a positive trajectory for future growth and value creation.
Investors can look forward to sustained performance and profitability as Owens & Minor navigates challenges and seizes growth opportunities in the evolving healthcare landscape.

Owens & Minor (OMI) reports robust Q4 earnings and outlines growth strategy for 2024

Owens & Minor (OMI) showcased strong financial performance in Q4 2023, with a positive outlook for 2024. Despite challenges in EBITDA calculations and deal delays, the company remains focused on strategic investments and operational optimization.

Owens & Minor (OMI) reports robust Q1 performance and growth outlook

Owens & Minor (OMI) delivered strong financial performance in Q1 2024, driven by revenue growth and margin expansion initiatives despite challenges in cash flow and debt reduction.
The company's strategic focus on operational efficiency, cost reduction, and long-term investments positions it well for future growth and market opportunities.
With a solid foundation in place and a clear growth strategy, Owens & Minor (OMI) is poised to navigate challenges and leverage opportunities for sustained success.

Owens & Minor reports revenue growth and strategic acquisitions in Q2

Owens & Minor's Q2 performance showed revenue growth and improved operating income, despite a GAAP net loss.
The acquisition of Rotech Healthcare strengthens the Patient Direct segment, driving revenue growth.
Challenges include managing costs, addressing tariffs' impact, and balancing segment optimization with expansion.
Opportunities exist in leveraging acquisitions, expanding product offerings, and enhancing operational efficiency.

Owens & Minor reports solid Q3 performance and eyes growth

Owens & Minor demonstrated resilience and strategic focus in Q3 2024, with strong financial results and debt reduction achievements.
While facing challenges such as supply chain issues and tariff impacts, the company remains optimistic about growth opportunities.
Investors can look forward to the Rotech acquisition and the company's commitment to operational excellence and market expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

NEW YORK, NY / ACCESSWIRE / July 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

Shareholders that lost money on Owens & Minor, Inc.(OMI) should contact Levi & Korsinsky about Securities Fraud Investigation - OMI

NEW YORK, NY / ACCESSWIRE / July 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

Investors who lost money on Owens & Minor, Inc. should contact Levi & Korsinsky about an ongoing investigation - OMI

OMI ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Owens & Minor, Inc.

NEW YORK, NY / ACCESSWIRE / July 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

Lost Money on Owens & Minor, Inc.(OMI)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky

NEW YORK, NY / ACCESSWIRE / July 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

Owens & Minor, Inc. (OMI) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates

Castle Biosciences Inc

National Research Corp

Pacira Pharmaceuticals

Cassava Sciences Inc

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Top 5 Health Care Stocks That May Explode In July

NEW YORK, NY / ACCESSWIRE / July 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

Owens & Minor, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Owens & Minor (OMI)

An Investigation Has Commenced on Behalf of Owens & Minor, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your OMI Losses.

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Owens & Minor Inc. (“OMI” or the “Company”) (NYSE: OMI) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On June 24, 2024, OMI announced that its Executive Vice President and Chief Financial Officer, Alexander J. Bruni, had “at the request of the Company, resigned from his position.

The Law Offices of Frank R. Cruz Announces Investigation of Owens & Minor Inc. (OMI) on Behalf of Investors

NEW YORK, NY / ACCESSWIRE / June 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

Shareholders that Lost Money on Owens & Minor, Inc.(OMI) Should Contact Levi & Korsinsky About Securities Fraud Investigation - OMI

NEW YORK, NY / ACCESSWIRE / July 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) concerning possible violations of federal securities laws. On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates.

OMI ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Owens & Minor, Inc. Shareholders Who Lost Money

Levi & Korsinsky Reminds Shareholders of an Investigation into Owens & Minor, Inc. (OMI) Regarding Potential Securities Fraud Allegations

NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Owens & Minor, Inc. (“Owens & Minor” or the “Company”) (NYSE: OMI) on behalf of Owens & Minor stockholders. Our investigation concerns whether Owens & Minor has violated the federal securities laws and/or engaged in other unlawful business practices.

OWENS & MINOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Owens & Minor, Inc. on Behalf of Owens & Minor Stockholders and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)---- $OMI #Investigation--The law firm of Kirby McInerney LLP is investigating potential claims against Owens & Minor, Inc. (“OMI” or the “Company”) (NYSE: OMI). The investigation concerns whether OMI and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [Click here to learn more about the investigation] On June 24, 2024, OMI announced that Alexander J. Bruni, the Company's Executive Vice President & Chief Financia.

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Owens & Minor Inc.

ATLANTA, June 27, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Owens & Minor, Inc. (“Owens & Minor” or the “Company”) (NYSE: OMI) complied with federal securities laws. On June 24, 2024, Owens & Minor announced that “the Company's Executive Vice President & Chief Financial Officer, has, at the request of the Company, resigned from his position as an officer of the Company, effective June 21, 2024.” Following this news, the price of the Company's stock dropped.

Investigation Into Owens & Minor, Inc. (OMI) Announced byHolzer & Holzer, LLC

BOSTON, MA / ACCESSWIRE / June 27, 2024 / Block & Leviton is investigating Owens & Minor Inc. (NYSE:OMI) for potential securities law violations. Investors who have lost money in their Owens & Minor Inc. investment should contact the firm to learn more about how they might recover those losses.

Owens & Minor ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

Block & Leviton is investigating Owens & Minor Inc. (OMI) for potential securities law violations. Investors who have lost money should contact the firm.

Owens & Minor Inc. Investigated for Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI), a global healthcare solutions company that provides healthcare products for home-based care, self-manufactured products, proprietary product portfolio, distribution services and innovative technology, announced today that Ed Pesicka, the Company's President and Chief Executive Officer and Alex Bruni, the Company's Executive Vice President and Chief Financial Officer, will participate in a webcasted fireside chat at 11:00 a.m.

Owens & Minor to Present at the Leerink Partners' Healthcare Crossroads Conference on May 29, 2024

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI), a global healthcare solutions company that provides healthcare products for home-based care, self-manufactured products, proprietary product portfolio, distribution services and innovative technology, announced today that Alex Bruni, the Company's Executive Vice President and Chief Financial Officer and Jonathan Leon, the Company's Senior Vice President-Finance and Corporate Treasurer, will be participating in a webcasted fire.

Owens & Minor to Present at the BofA Securities 2024 Health Care Conference on May 15, 2024

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Owens & Minor (OMI) Stock?

Owens & Minor, Inc. (NYSE:OMI ) Q1 2024 Earnings Conference Call May 3, 2024 8:30 AM ET Company Participants Jacqueline Marcus - Investor Relations, Alpha IR Group Edward Pesicka - President and Chief Executive Officer Alexander Bruni - Executive Vice President and Chief Financial Officer Conference Call Participants Michael Cherny - Leerink Partners Kevin Caliendo - UBS Daniel Grosslight - Citi Research Eric Coldwell - Robert W. Baird Stephanie Davis - Barclays Capital Allen Lutz - Bank of America Operator Good day, and thank you for standing by.

Owens & Minor, Inc. (OMI) Q1 2024 Earnings Call Transcript

The headline numbers for Owens & Minor (OMI) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Owens & Minor (OMI) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor Reports First Quarter 2024 Financial Results.

Owens & Minor Reports First Quarter 2024 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the first quarter of 2024 on Friday, May 3, 2024, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested.

Owens & Minor Announces First Quarter 2024 Earnings Release Date and Conference Call

Addus HomeCare

Catalyst Pharmaceuticals

Integer Holdings

Progyny

CNBC's Jim Cramer said he thinks it could be a good year for small cap stocks and shared his top picks.

News for Owens & Minor Stock (OMI)